Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.
暂无分享，去创建一个
J. Esteve | D. Colomer | Marcos González | E. Vellenga | M. Calasanz | P. Bolufer | E. Barragán | M. Sanz | S. Brunet | B. Löwenberg | C. Chillón | J. Bergua | B. Lowenberg | S. Negri | P. Montesinos | G. Milone | J. de la Serna | J. Serna | R. Parody | C. Rivas | J. García-Laraña | C. Rayón | J. González | A. León | E. Amutio | C. Chillón | José D. González | C. Chillon